Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, July 31 2014 9:54pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Thursday, Jul 31, 2014
·pSivida Corp. Reports ILUVIEN® for Chronic Diabetic Macular Edema Receives Marketing Authorization in Denmark, 9th EU Approval
Business Wire - Thu 4:05 pm ET
·Valeant shares fall on lowered 2014, 2015 forecasts
Reuters - Thu 4:04 pm ET
·As Valeant's Stock Drops, So Does Its Takeover Price for Allergan
at The Wall Street Journal Online - Thu 2:29 pm ET
·Valeant forecast overshadows strong quarter
AP - Thu 1:04 pm ET
·How Will Valeant (VRX) Stock React To CEO's Acquisition Comments?
at - Thu 12:48 pm ET
·Alkermes plc Reports Second Quarter 2014 Financial Results
Business Wire - Thu 7:00 am ET
·Columbia Laboratories Reports Second Quarter 2014 Financial Results
PR Newswire - Thu 7:00 am ET
·Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis
PR Newswire - Thu 7:00 am ET
·Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results
CNW Group - Thu 6:00 am ET
·Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results
PR Newswire - Thu 6:00 am ET
Wednesday, Jul 30, 2014
·Alkermes Announces Initiation of FORWARD-5 Clinical Study of ALKS 5461 For Treatment of Major Depressive Disorder
Business Wire - Wed 7:00 am ET
Tuesday, Jul 29, 2014
·IntelliPharmaCeutics (IPCI): Moving Average Crossover Alert - Tue Jul 29
·FDA Accepts for Review Adamis' New Drug Application for Its Epinephrine Pre-Filled Syringe
Marketwire - Tue Jul 29
·Flamel Technologies Announces Second Quarter of Fiscal Year 2014 Results
Marketwire - Tue Jul 29
Monday, Jul 28, 2014
·pSivida Announces ILUVIEN® Receives Marketing Authorization in Norway and Approval for Reimbursement in Portugal
Business Wire - Mon Jul 28
·[video] Allergan's Largest Shareholder Sells Most of Holdings
at MarketWatch - Mon Jul 28
Thursday, Jul 24, 2014
·Acura Pharmaceuticals to Host Second Quarter 2014 Financial Results Conference Call on August 5, 2014
Marketwire - Thu Jul 24
·Alkermes to Host Conference Call to Discuss Second Quarter 2014 Financial Results
Business Wire - Thu Jul 24
·Wall Street Junk Euphoria Backs Ackman’s Allergan Dreams
at Bloomberg - Thu Jul 24
·Valeant files official complaint about Allergan with Canadian regulator
at MarketWatch - Thu Jul 24
More Latest News...
Sponsor Results
HRP-Based Antibody Arrays
HRP label-based antibody arrays. High sensitivity, many targets!
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
3DOF Orientation Tracker
Small accurate IMU for 3D measurement of human body segments and more.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?